세계의 GI 대변 검사 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
GI Stool Testing Market (Product Type: Consumables and Analyzers, and Test Type: Occult Blood Test, Ova and Parasites Test, Fecal Biomarkers Test, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1531002
리서치사:Transparency Market Research
발행일:2024년 06월
페이지 정보:영문 148 Pages
라이선스 & 가격 (부가세 별도)
한글목차
이 보고서는 2024-2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 세계 GI 대변 검사 시장에 대해 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018-2034년까지의 세계 GI 대변 검사 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 GI 대변 검사 시장의 연평균 성장률(CAGR%)도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 GI 대변 검사 시장을 추론했습니다.
시장 현황
2023년 시장 규모
5억 5,500만 달러
2034년 시장 규모
13억 달러
CAGR
7.7%
이 보고서는 세계 GI 대변 검사 시장의 경쟁 환경을 조사했습니다. 세계 GI 대변 검사 시장에서 사업을 전개하는 주요 업체들이 확인되었으며, 각 업체는 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 GI 대변 검사 시장의 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
COVID-19의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 제품 유형별
서론과 정의
주요 조사 결과·발전
시장 매출 예측 : 제품 유형별, 2020-2034년
소모품
애널라이저
시장 매력 분석 : 제품 유형별
제7장 세계 시장 분석과 예측 : 검사 유형별
서론과 정의
주요 조사 결과·발전
시장 매출 예측 : 검사 유형별, 2020-2034년
잠혈 검사
난자 및 기생충 검사
분변 바이오마커 검사
기타(세균 검사 등)
시장 매력 분석 : 검사 유형별
제8장 세계 시장 분석과 예측 : 적응증별
서론과 정의
주요 조사 결과·발전
시장 매출 예측 : 적응증별, 2020-2034년
감염증
염증성 장질환
위식도 역류증
암
기타
시장 매력 분석 : 적응증별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과·발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원
진단센터 및 검사실
학술기관
연구센터 및 조직
기타
시장 매력 분석 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 분석 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Abbott Laboratories
Beckman Coulter, Inc.
Bio-Rad Laboratories
BioMerieux Inc.
Cardinal Health, Inc.
Cenogenics Corporation
Epitope Diagnostics, Inc.
ScheBo Biotech AG
Quest Diagnostics
Genova Diagnostics
LSH
영문 목차
영문목차
GI Stool Testing Market - Scope of Report
TMR's report on the global GI stool testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global GI stool testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global GI stool testing market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the GI stool testing market.
Market Snapshot
Market Value in 2023
US$ 555 Mn
Market Value in 2034
US$ 1.3 Bn
CAGR
7.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global GI stool testing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global GI stool testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global GI stool testing market.
The report delves into the competitive landscape of the global GI stool testing market. Key players operating in the global GI stool testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global GI stool testing market profiled in this report.
Key Questions Answered in Global GI stool testing Market Report:
What is the sales/revenue generated by GI stool testing across all regions during the forecast period?
What are the opportunities in the global GI stool testing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
GI Stool Testing Market - Research Objectives and Research Approach
The comprehensive report on the global GI stool testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global GI stool testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global GI stool testing market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global GI Stool Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global GI Stool Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global GI Stool Testing Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Consumables
6.3.2. Analyzers
6.4. Market Attractiveness, by Product Type
7. Global GI Stool Testing Market Analysis and Forecast, by Test Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Occult Blood Test
7.3.2. Ova and Parasites Test
7.3.3. Fecal Biomarkers Test
7.3.4. Others (Bacteria Test, etc.)
7.4. Market Attractiveness, by Test Type
8. Global GI Stool Testing Market Analysis and Forecast, by Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
8.3.1. Infection
8.3.2. Inflammatory Bowel Disease
8.3.3. Gastroesophageal Reflux Disease
8.3.4. Cancer
8.3.5. Others (Poor Absorption Problems, etc.)
8.4. Market Attractiveness, by Indication
9. Global GI Stool Testing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Diagnostic Centers & laboratories
9.3.3. Academic Institutes
9.3.4. Research Centers & Organizations
9.3.5. Others (Homecare Settings, etc.)
9.4. Market Attractiveness, by End-user
10. Global GI Stool Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America GI Stool Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Consumables
11.2.2. Analyzers
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Occult Blood Test
11.4.2. Ova and Parasites Test
11.4.3. Fecal Biomarkers Test
11.4.4. Others (Bacteria Test, etc.)
11.5. Market Attractiveness, by Test Type
11.6. Market Value Forecast, by Indication, 2020-2034
11.6.1. Infection
11.6.2. Inflammatory Bowel Disease
11.6.3. Gastroesophageal Reflux Disease
11.6.4. Cancer
11.6.5. Others (Poor Absorption Problems, etc.)
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Diagnostic Centers & laboratories
11.8.3. Academic Institutes
11.8.4. Research Centers & Organizations
11.8.5. Others (Homecare Settings, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Test Type
11.11.3. By Indication
11.11.4. By End-user
11.11.5. By Country
12. Europe GI Stool Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Consumables
12.2.2. Analyzers
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Occult Blood Test
12.4.2. Ova and Parasites Test
12.4.3. Fecal Biomarkers Test
12.4.4. Others (Bacteria Test, etc.)
12.5. Market Attractiveness, by Test Type
12.6. Market Value Forecast, by Indication, 2020-2034
12.6.1. Infection
12.6.2. Inflammatory Bowel Disease
12.6.3. Gastroesophageal Reflux Disease
12.6.4. Cancer
12.6.5. Others (Poor Absorption Problems, etc.)
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Diagnostic Centers & laboratories
12.8.3. Academic Institutes
12.8.4. Research Centers & Organizations
12.8.5. Others (Homecare Settings, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Test Type
12.11.3. By Indication
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific GI Stool Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Consumables
13.2.2. Analyzers
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Occult Blood Test
13.4.2. Ova and Parasites Test
13.4.3. Fecal Biomarkers Test
13.4.4. Others (Bacteria Test, etc.)
13.5. Market Attractiveness, by Test Type
13.6. Market Value Forecast, by Indication, 2020-2034
13.6.1. Infection
13.6.2. Inflammatory Bowel Disease
13.6.3. Gastroesophageal Reflux Disease
13.6.4. Cancer
13.6.5. Others (Poor Absorption Problems, etc.)
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Diagnostic Centers & laboratories
13.8.3. Academic Institutes
13.8.4. Research Centers & Organizations
13.8.5. Others (Homecare Settings, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Test Type
13.11.3. By Indication
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America GI Stool Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Consumables
14.2.2. Analyzers
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Occult Blood Test
14.4.2. Ova and Parasites Test
14.4.3. Fecal Biomarkers Test
14.4.4. Others (Bacteria Test, etc.)
14.5. Market Attractiveness, by Test Type
14.6. Market Value Forecast, by Indication, 2020-2034
14.6.1. Infection
14.6.2. Inflammatory Bowel Disease
14.6.3. Gastroesophageal Reflux Disease
14.6.4. Cancer
14.6.5. Others (Poor Absorption Problems, etc.)
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Diagnostic Centers & laboratories
14.8.3. Academic Institutes
14.8.4. Research Centers & Organizations
14.8.5. Others (Homecare Settings, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Test Type
14.11.3. By Indication
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa GI Stool Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Consumables
15.2.2. Analyzers
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Test Type, 2020-2034
15.4.1. Occult Blood Test
15.4.2. Ova and Parasites Test
15.4.3. Fecal Biomarkers Test
15.4.4. Others (Bacteria Test, etc.)
15.5. Market Attractiveness, by Test Type
15.6. Market Value Forecast, by Indication, 2020-2034
15.6.1. Infection
15.6.2. Inflammatory Bowel Disease
15.6.3. Gastroesophageal Reflux Disease
15.6.4. Cancer
15.6.5. Others (Poor Absorption Problems, etc.)
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Diagnostic Centers & laboratories
15.8.3. Academic Institutes
15.8.4. Research Centers & Organizations
15.8.5. Others (Homecare Settings, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Test Type
15.11.3. By Indication
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Beckman Coulter, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bio-Rad Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. BioMerieux Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Cardinal Health, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Cenogenics Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Epitope Diagnostics, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. ScheBo Biotech AG
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Quest Diagnostics
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genova Diagnostics
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
